Search Medical Condition
Please enter condition
Please choose location from dropdown

Lawrenceville, Georgia Clinical Trials

A listing of Lawrenceville, Georgia clinical trials actively recruiting patient volunteers.

RESULTS

Found (119) clinical trials

Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise

Study duration per participant is approximately 65 weeks, including a 3-week screening period, 30 weeks core treatment period, 26 weeks extension treatment period, and 6 weeks safety follow up.

Phase

2.05 miles

Learn More »

PSD502 in Subjects With Premature Ejaculation

The study will assess whether the bothersome symptoms of premature ejaculation (PE) are helped when treated with PSD502 by answering questionnaires such as the 'Premature Ejaculation Bothersome Evaluation Questionnaire' (PEBEQ) and 'Index of Premature Ejaculation (IPE) and some additional questions about premature ejaculation. The study will also measure the effect ...

Phase

2.05 miles

Learn More »

A Rigorous Evaluation of the Relationship Between Physical Activity and Education Outcomes

Serving more than 95% of US children ages 5-17, the school environment is a valuable setting to engage students in Physical Activity (PA) through the day, but is limited when physical education programs have insufficient curricular, time, financial and staffing allocations. A growing body of research supports the premise that ...

Phase N/A

2.05 miles

Learn More »

The National Amyotrophic Lateral Sclerosis Registry

The National ALS Registry's Research Notification System allows person with ALS to participate in clinical trials.

Phase N/A

3.11 miles

Learn More »

NeuroTrials Research is conducting a 20-month, placebo-controlled research study evaluating an investigational drug for Alzheimer’s Disease. Study-related exams and study drug are provided at no cost. Qualified participants and caregivers will be compensated for time and travel. Patient Inclusion Criteria: Age 50-89 Diagnosis of probable Alzheimer’s Disease Must have a ...

Phase

3.11 miles

Learn More »

NeuroTrials Research is conducting a new study for an inhalant for patients with COPD (chronic obstructive bronchitis or emphysema). Qualified participants receive compensation for time and travel as well as study drug and study-related exams at no cost. Patient Inclusion Criteria: Age 40 and older Current or former smoker Otherwise ...

Phase

3.11 miles

Learn More »

Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection

Summit is developing ridinilazole as a novel antimicrobial for Clostridium difficile Infection (CDI) with the goal of achieving comparable cure rates to standard of care, but reducing rates of recurrent disease. A phase 2 proof of concept study, with vancomycin as comparator, demonstrated these attributes with a comparable safety profile. ...

Phase

3.11 miles

Learn More »

Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines

A prospective, randomized open-label clinical trial will be conducted from July 2018 to October 2020. Approximately 300 preterm infants will be enrolled across three sites: Duke University Medical Center, the University of North Carolina, and Cincinnati Children's Hospital Medical Center. Eligible infants will be randomized 1:1 to receive either 2-month ...

Phase

3.11 miles

Learn More »

Study Comparing Emergency Contraception Effectiveness in Women Who Weight 80 kg

Orally-dosed emergency contraception (EC) is highly effective when used properly. EC is up to 90% effective at preventing pregnancy following unprotected intercourse. Both ulipristal acetate (UPA) and levonorgestrel (LNG) delay or inhibit ovulation when used for EC. For individual women, use of EC provides a critical backup to prevent unintended ...

Phase

4.31 miles

Learn More »

Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy Surgery and/or Radiation Therapy

This is a randomized double-blind placebo-controlled phase III trial of aspirin (300 mg daily) in early stage node-positive HER2 negative breast cancer patients. Patients will be randomized 1:1 within stratum defined by: Hormone Receptor status (HR positive vs HR negative), body mass index (<30 vs 30 kg/m2) and stage (Stage ...

Phase

4.75 miles

Learn More »